{{Rsnum
|rsid=1532701
|Gene=SLC6A2
|Chromosome=16
|position=55664115
|Orientation=plus
|GMAF=0.4477
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC6A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 28.3 | 53.1 | 18.6
| HCB | 41.2 | 39.7 | 19.1
| JPT | 30.1 | 51.3 | 18.6
| YRI | 26.5 | 47.6 | 25.9
| ASW | 29.8 | 36.8 | 33.3
| CHB | 41.2 | 39.7 | 19.1
| CHD | 34.9 | 42.2 | 22.9
| GIH | 35.6 | 50.5 | 13.9
| LWK | 14.5 | 55.5 | 30.0
| MEX | 41.4 | 48.3 | 10.3
| MKK | 25.0 | 46.8 | 28.2
| TSI | 40.2 | 46.1 | 13.7
| HapMapRevision=28
}}Trajectories of change in [[depression]] severity during treatment with [[antidepressants]].{{PMID|19863842}}

Pharmacogenomics of antidepressant drugs.{{PMID|19563827}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{PMID Auto
|PMID=20818294
|Title=A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese.
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}